Healthy Lifestyle May Curb Age-Related Brain Disease Risk
It's often emphasized that a healthier lifestyle can lead to a longer life, but a recent study of participants from the UK Biobank showed that healthy lifestyle behaviors may help reduce the risk for age-related brain diseases.
Results of new research show participants with shorter leukocyte telomere length (LTL) were more likely to develop age-related brain diseases, including dementia, stroke, and late-life depression, than those who had longer LTL.
However, engaging in healthy lifestyle behaviors appeared to offset these risk factors. Although the study does not establish causality, the findings suggest that the association between shorter LTL and age-related brain diseases may be modifiable.
'Our findings support the potential benefits of working to improve your risk factors such as maintaining a healthy weight, limiting alcohol, and getting enough sleep and exercise in reducing the risk of age-related brain disease even in people who are already showing signs of damaging biological aging,' senior author Christopher D. Anderson, MD, MMSc, of Harvard Medical School in Boston, said in a press release.
The results were published on June 11 in the journal Neurology .
Unhealthy Lifestyle and Age-Related Brain Diseases
Telomeres are often described as protective caps on the end of chromosomes, and shortened telomeres have been associated with age, race, sex, adverse environmental exposures, and genetic factors, as well as lifestyle factors such as physical activity, diet, alcohol, nutrition, sleep, stress, aerobic activity social interactions, and smoking using the Brain Care Score (BCS). A BCS of 15 or higher was associated with healthier lifestyle choices, while a BCS of 10 or lower signified less healthy lifestyle choices.
What has been less clear up to this point is the degree to which LTL affects age-related brain diseases, and whether changing an individual's lifestyle habits could influence LTL, as opposed to LTL being a predictor of the risk for age-related brain disease.
Researchers evaluated 356,173 participants from the UK Biobank with a median age of 56 years. Recruitment of participants occurred between 2006 and 2010, and there were four follow-up assessments in 2012-2013, 2014, 2019, and 2023. Participants were included if they had data on biomarkers such as LTL and DNA, as well as clinical data to identify potential risk factors for age-related brain disease using the BCS.
The primary outcome was the association between LTL and the risks for stroke, dementia, and late-life depression, both as a composite outcome and as individual outcomes.
LTL was categorized into three tertiles, ranging from shortest to longest, and risk factors were compared across these groups using the BCS. A BCS of 15 or higher indicated healthier lifestyle choices — such as a nutritious diet, a low cholesterol level, and controlled blood pressure — while a BCS of 10 or lower reflected less healthy behaviors.
The results showed the shortest LTL tertile was associated with an increased risk for the age-related brain disease composite outcome (hazard ratio [HR], 1.11; 95% CI, 1.08-1.15), as well as increased risks for dementia (HR, 1.19; 95% CI, 1.12-1.26), late-life depression (HR, 1.14; 95% CI, 1.09-1.18), and stroke (HR, 1.08; 95% CI, 1.02-1.15).
When comparing participants with shorter LTL, those with a lower BCS were at a higher risk for the age-related brain disease composite outcome (HR, 1.11; 95% CI, 1.07-1.16), as well as for dementia (HR, 1.17; 95% CI, 1.08-1.28), late-life depression (HR, 1.13; 95% CI, 1.07-1.19), and stroke alone (HR, 1.10; 95% CI, 1.02-1.19).
Among participants with shorter LTL but a higher BCS, there were no significant increases in the risk for age-related brain disease as a composite or individual outcomes.
Reversing Risk
Limitations of the study included the evaluation of participants with only European ancestry, and measurement of LTL was conducted at baseline rather than over time. Future studies should include assessing the relationship between shortened LTL and age-related brain diseases in more diverse populations, as well as measuring LTL over time, the researchers said.
However, the findings suggest 'healthy lifestyle behaviors could delay the aging of our cells and reduce the frequency of these diseases, especially in people who are greater risk,' said Anderson.
'Reducing risk factors like weight and alcohol consumption, as well as getting more sleep and exercise, can all help reverse the risk of age-related brain diseases, even for people who are already showing signs of biological aging,' lead author Tamara Kimball, MD, of the Center for Neurotechnology and Neurorecovery at Massachusetts General Hospital, Boston, said in the press release. 'In short, it is never too late to start taking better care of your brain.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
an hour ago
- Associated Press
US Lab Partners and SciSure Launch Strategic Partnership to Transform EHS Services and Lab Operations
BOSTON MA - SciSure, the Scientific Management Platform (SMP) designed to unify scientific research, safety, operations, and compliance, today announced a strategic partnership with US Lab Partners, a leader in lab and facility operations and EHS (Environmental Health & Safety) consulting. Together, the organizations are launching a transformative 'Virtual Incubator Model' that gives emerging and scaling life science organizations affordable access to world-class digital lab infrastructure and operational support. Unlocking Modern Lab Management for Scientific Entrepreneurs Emerging life science organizations have long faced a costly challenge: accessing high-quality EHS, lab operations, and compliance infrastructure before they have the resources or scale to support large software investments. The new SciSure and US Lab Partners collaboration eliminates this barrier. By combining SciSure's comprehensive, scalable software suite with US Lab Partners' expert consulting and implementation services, these organizations can now operate efficient, safe, and compliant labs from day one. 'Our customers have often told us they needed digital infrastructure long before they had the budget or internal resources to manage it,' said Philip Meer, CEO of SciSure. 'This partnership ensures they no longer have to choose between premium software or on-the-ground expert services - they get both, seamlessly integrated.' Better Together: A Complete Solution for Emerging Labs US Lab Partners provides deep, hands-on expertise in lab setup, operations, and EHS compliance. They become an extension of the customer's internal team, guiding labs through complex requirements and day-to-day operations. SciSure complements this with an industry-leading platform encompassing Electronic Lab Notebooks (ELN), Laboratory Information Management Systems (LIMS), inventory tracking and EHS workflows, all in one secure and scalable environment. 'Too often, emerging scientific companies are forced to rely on underpowered tools, systems that create data silos and are little more than glorified spreadsheets,' said Jon Zibell, Vice President of Global Alliances and Marketing at SciSure. 'This partnership is designed to change that. We are delivering a seamless digital experience from day one, without sacrificing safety, compliance, or data integrity.' 'Digitizing lab operations is no longer optional - it's critical for continuity, safety, and scientific integrity,' said Demet Aybar, CEO and Founder of US Lab Partners. 'Together with SciSure, we're delivering world-class software and hands-on expertise that have traditionally been reserved for Big Pharma, now accessible to startups and academic innovators.' Impacting the Future of Scientific Innovation This partnership marks a pivotal shift in how scientific organizations can launch and operate. By eliminating the traditional burden of high costs, fragmented systems, and lack of technical resources, the Virtual Incubator Model accelerates innovation while reducing overhead and risk. Customers now gain access to a fully digital and seamlessly integrated record-keeping system from day one, end-to-end EHS and inventory management software and services, a robust LMS with training content library, tusted partners who bring both software and service to manage lab setup, safety, and compliance, as well as ELN, LIMS, SOP's, and Sample Management built-in. 'This model reflects our shared mission: to help brilliant science thrive without operational bottlenecks,' Aybar added. 'We're here to make world-class lab infrastructure available without compromise.' Media Contact Company Name: SciSure Contact Person: Anne-Marie Miscioscia Email: Send Email Country: United States Website: Source: PR Company
Medscape
4 hours ago
- Medscape
Fast Five Quiz: Ovarian Cancer Overview
Ovarian cancer poses a significant threat to women's health, often developing quietly and without early symptoms. It is commonly discovered after progression. This late detection, along with resistance to treatment and frequent relapse, contributes to poor outcomes. Although medical and surgical interventions have evolved, survival rates remain low. These challenges highlight the critical importance of early detection methods, precise diagnostic technologies, and individualized care coordinated across medical specialties. How much do you know about ovarian cancer? Test your knowledge with this quick quiz. High-grade serous carcinoma is by far the most prevalent, representing approximately 70%-80% of epithelial ovarian cancer cases. In contrast, the low-grade form of serous carcinoma is much less common (< 5%). Endometrioid and clear cell subtypes are each responsible for about 10% of cases and have known associations with endometriosis. Mucinous carcinomas are uncommon, comprising a small fraction (around 3%) of epithelial ovarian cancers. Learn more about ovarian cancer. According to the National Institute for Health and Care Excellence guidelines, for patients with inherited mutations linked to a higher chance of developing ovarian cancer (eg, alterations in BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 ), the most effective preventive surgical procedure is the bilateral salpingo-oophorectomy (which is the removal of both fallopian tubes and ovaries). This intervention has been proven to greatly reduce ovarian cancer risk and enhance long-term survival among these high-risk groups. However, when performed in premenopausal women, it induces menopause. Removing one ovary (unilateral oophorectomy) or the uterus (total hysterectomy) does not offer adequate protection against ovarian cancer. Procedures like cervical conization are unrelated to ovarian cancer and are used to manage cervical abnormalities. Learn more about salpingo-oophorectomy. HRT is typically recommended for women who undergo bilateral salpingo-oophorectomy before reaching the natural age of menopause and have not had breast cancer. This type of surgery causes a sudden and early drop in estrogen levels, which can result in bothersome symptoms and increase the risk for long-term health issues such as bone loss or cardiovascular problems. HRT helps ease these effects and maintain health until the typical menopausal age. In contrast, women older than age 50 years are often already in or near menopause, and HRT is not routinely needed unless specific symptoms arise. Patients who have a history of breast cancer must be assessed on a case-by-case basis because HRT might not be safe. Women with a uterus should be offered combined HRT, whereas women without a uterus should be offered estrogen-only HRT. Additionally, women who have not had their ovaries removed do not experience the abrupt hormonal shift that warrants preventive HRT. Learn more about HRT. Individuals who carry a BRCA1 mutation face a significantly elevated risk of developing ovarian cancer, often at a younger age than those with other hereditary mutations. If a woman with a BRCA1 mutation decides not to undergo surgery to remove her ovaries and fallopian tubes, monitoring for early signs of cancer should begin after age 35 years. This timing aligns with evidence suggesting that BRCA1 -related ovarian cancers tend to occur earlier than those linked to BRCA2 or other genetic variants. Initiating surveillance at age 30 years is generally premature and not part of standard recommendations. For BRCA2 carriers, screening is usually deferred until after age 40 years, whereas those with alterations in genes like RAD51C, RAD51D, BRIP1 , or PALB2 typically begin surveillance after age 45 years. Individuals with Lynch syndrome-related mutations (eg, MLH1, MSH2, MSH6 ) are also advised to start at age 35 years if surgery is postponed. Learn more about breast cancer risk factors. Although mucinous tumors can arise directly from the ovary, many are actually secondary cancers that have spread from other organs, most notably the gastrointestinal system, including the colon and appendix. Distinguishing between primary and metastatic mucinous tumors is crucial for proper diagnosis and management. High-grade serous cancers more commonly begin in the epithelium of the fallopian tubes rather than the ovaries. On the other hand, low-grade serous carcinomas are thought to originate in the ovary and are typically diagnosed in younger females, with outcomes generally more favorable than their high-grade counterparts. Germ cell tumors and sex cord-stromal tumors are far more frequent in adolescents and young adults, with most cases occurring before age 30 years and not in women older than 45. Learn more about endometrioid carcinoma.
Yahoo
8 hours ago
- Yahoo
Opinion - Medically tailored nutrition can help make America healthy
Chronic disease is a threat not only to Americans' physical health but also to the nation's financial health. Conditions like heart disease, cancer, diabetes and kidney failure account for trillions of dollars in annual health care spending and are among the leading causes of death in the U.S. The growing consensus is clear that our health care system needs better solutions to manage chronic diseases. One promising tool is surprisingly simple: food. But not just any food. We need nutritious, locally sourced, medically tailored meals — food-based interventions designed by registered dietitian nutritionists specifically for chronically ill Americans. These medically tailored meals are proven to improve health outcomes, reduce hospitalizations and lower health care costs. Just as important, they can reduce patients' dependency on medications, making health care more effective and affordable. At the Boston-based nonprofit I lead, we have seen firsthand how medically tailored meals can transform lives. One of our clients, for example, reduced his daily medications from 14 to just four after enrolling in our program. This is what we mean when we say 'food is medicine' — food, either alone or in conjunction with pharmaceuticals, can help patients become and stay healthier. These meals are not only about nourishment. They are about addressing the root causes of chronic diseases while offering real cost savings. Medically tailored meals prioritize nutrition, treating the underlying causes of disease, not just symptoms. They reduce dependence on medication, leading to fewer prescriptions and better health outcomes. These meals prioritize fresh ingredients over processed foods, with a commitment to quality local food. They lead to immediate cost savings, with reductions in hospitalizations and medical costs. And they support local businesses, strengthening local farms and fishing industries through prioritization of regional sourcing. Does it work? The evidence is clear. Studies published in JAMA and Health Affairs show that medically tailored meals reduce hospitalizations by 49 percent and emergency room visits by 70 percent. They have also been shown to lower total medical costs by a remarkable 16 percent. Another recent study published in Health Affairs estimates that a nationwide rollout of medically tailored meals could save $32 billion annually. In a time of policy uncertainty, one thing is clear: 'Food is medicine' is a bipartisan opportunity to transform health care. The Make America Healthy Again movement is dedicated to reducing the burden of chronic diseases, decreasing reliance on pharmaceuticals and integrating nutrition into health care. The Senate MAHA Caucus is already focused on improving access to high-quality, nutrient-dense foods and addressing the root causes of disease. Congress should act now to expand medically tailored nutrition for veterans, older Americans and people with disabilities — groups who stand to benefit the most. Let us seize this moment and make medically tailored nutrition a central part of making America healthy again. David B. Waters is the CEO of Community Servings, a Boston-based nonprofit provider of medically tailored meals and nutrition services, and founder of the AMPL Institute. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
